Inter-TH in breast cancer has led to the classification based on histology and expression profiles of the molecular markers; oestrogen receptor (ER), progesterone receptor (PR) and the overexpression or gene amplification of human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ESR1 and breast carcinoma.